Browse > Article
http://dx.doi.org/10.5487/TR.2009.25.1.047

Genotoxic Evaluation of Surfactin C in Chinese Hamster Lung Cell Line  

Lim, Jong-Hwan (B&C Biopharm)
Song, In-Bae (Institute of Veterinary Animal Science, Chungnam National University)
Park, Byung-Kwon (JEONJIN BIO)
Kim, Myoung-Seok (Institute of Veterinary Animal Science, Chungnam National University)
Hwang, Youn-Hwan (Institute of Veterinary Animal Science, Chungnam National University)
Yun, Hyo-In (Institute of Veterinary Animal Science, Chungnam National University)
Publication Information
Toxicological Research / v.25, no.1, 2009 , pp. 47-50 More about this Journal
Abstract
To investigate the mutation inducibility of surfactin C, we performed the chromosome aberration assay with Chinese hamster lung cells in vitro. The colorimetric MTT screening assay was carried out to determine the cytotoxicity index ($IC_{50}$) of surfactin C. The $IC_{50}$ value was $125{\mu}g/ml$. For the chromosome aberration test of surfactin C, the maximum concentration was employed as $125{\mu}g/ml$, followed by 62.5 and $31.25{\mu}g/ml$ for the lower concentrations, with or without metabolic activation (S9). Cyclophosphamide and mitomycin C were used as positive controls in the presence and absence of S9 metabolic activation, respectively. These results showed that surfactin C was not capable of inducing chromosome aberration, as measured by the chromosome aberration test using Chinese hamster lung cell line. There is no evidence for surfactin C to have a genotoxic potential.
Keywords
Surfactin C; Chromosome aberration test; MTT test; Chinese Hamster Cell;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Dearfield, K.L., Cimino, M.C., McCarroll, N.E., Mauer, I. and Valcovic, L.R. (2002), Genotoxicity risk assessment: a proposed classification strategy, Mutat. Res., 521, 121-135   DOI   PUBMED   ScienceOn
2 Mulligan, C.N. (2005), Environmental applications for biosurfactants, Environ Pollut., 133, 183-198   DOI   ScienceOn
3 O'Brien, P.J., Hales, B.F., Josephy, P.D., Castonguay, A., Yamazoe, Y. and Guengerich, F.P. (1996), Chemical carcinogenesis, mutagenesis and teratogenesis, Can. J. Physiol. Pharmacol., 74, 565-571   DOI   ScienceOn
4 Lim, J.H., Park, B.K., Kim, M.S., Hwang, M.H., Rhee, M.H., Park, S.C. and Yun, H.I. (2005), The anti-thrombotic activity of surfactins, J. Vet. Sci., 6, 353-355   PUBMED
5 Hwang, M.H., Lim, J.H., Yun, H.I., Rhee, M.H., Cho, J.Y., Hsu, W.H. and Park, S.C. (2005b), Surfactin C inhibits the lipopolysaccharide- induced transcription of interleukin-1beta and inducible nitric oxide synthase and nitric oxide production in murine RAW 264.7 cells, Biotechnol Lett., 27, 1605-1608   DOI   ScienceOn
6 Hwang, M.H., Lim, J.H., Kim, K.S., Rhee, M.H., Kim, N.W., Kim, J.C. and Park, S.C. (2005a), Antibacterial activity in vitro and primary dermal irritationtest in rabbits of surfactin produced in bacillus subtilus complex BC2121, J. Toxicol. Pub. Health, 20, 39-43
7 Arima, K., Kakinuma, A. and Tamura, G. (1968), Surfactin, a crystalline peptidolipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation, Biochem. Res. Commun., 31, 488-494   DOI   ScienceOn
8 Park, B.K., Lim, J.H., Hwang, Y.H., Kim, M.S., Song, I.B., Lee, H.G., Han, S.J., Hwang, M.H., Kim, J.W., Park, S.C., Rhee, M.H. and Yun, H.I. (2006), Acute oral toxicity of surfactin C in mice, J. Toxicol. Pub. Health, 22, 453-458   과학기술학회마을
9 Singh, P. and Cameotra, S.S. (2004), Potential applications of microbial surfactants in biomedical sciences, Trends Biotechnol.,22, 142-146   DOI   ScienceOn
10 Galloway, S., Aardema, M., Ishidate, M., Ivett, J., Kirkland D., Morita, T., Mosesso, P. and Sofuni, T. (1994), Report from the working group on in vitro tests for chromosomal aberrations, Mutat. Res., 312, 241-262   DOI   PUBMED   ScienceOn
11 Hwang, Y.H., Park, B.K., Lim, J.H., Kim, M.S., Song, I.B., Park, S.C. and Yun, H.I. (2008), Evaluation of genetic and developmental toxicity of surfactin C from Bacillus subtilis BC1212, J. Health Sci., 54, 101-106   DOI   ScienceOn
12 Desai, J.D. and Banat, I.M. (1997), Microbial production of surfactants and their commercial potential, Microbiol. Mol. Biol. Rev., 61, 47-64   PUBMED
13 Georgiou, G., Liu, S.C. and Sharma, M.M. (1990), Surface active compounds from microorganisms, Biotechnol., 10, 60-65   DOI   ScienceOn
14 Scott, D., Danford, N., Dean, B., Kirkland, D. and Richardson C. (1983), In vitro chromosome aberration assays, Report of the UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Part 1, Cambridge University Press, Cambridge, UK, pp. 41-64
15 Kanatomo, S., Nagai, S., Ohki, K. and Yasuda, Y. (1995), Study on surfactin, a cyclic depsipeptide. I. Isolation and structure of eight surfuctin analogs produced by Bacillus natto KMD 2311, Yakugaku. Zasshi., 115, 756-764   DOI   PUBMED
16 Takahashi, T., Ohno, O., Ikeda, Y., Sawa, R., Homma, Y., Igarashi, M. and Umezawa, K. (2006), Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin, J. Antibiot (Tokyo), 59, 35-43   DOI   PUBMED
17 Banat, I.M., Makkar, R.S. and Cameotra, S.S. (2000), Potential commercial applications of microbial surfactants, Appl. Microbiol. Biotechnol., 53, 495-508   DOI   ScienceOn
18 Organization for Economic Cooperation and Development(OECD, 1997). Test Guideline 473, In vitro Mammalian chromosome aberration test. In: OECD Guidelines for the Testing of Chemicals. OECD Paris
19 Kikuchi, T. and Hasumi, K. (2002), Enhancement of plasminogen activation surfactin C: augmentation of fibrinolysis in vitro and in vivo, Biochem. Biophys. Acta., 1596, 234-245   DOI   ScienceOn
20 Rodrigues, L., Banat, I.M., Teixeira, J. and Oliveira, R. (2006), Biosurfactants: potential applications in medicine, J. Antimicrob.Chemother., 57, 609-618   DOI   ScienceOn